New dialyzer shows promise in small safety trial

NCT ID NCT07058909

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a new dialysis filter called ELISIO-HX in 22 adults with kidney failure. Participants used the new filter three times a week for 12 weeks. The goal was to see if it safely maintained albumin levels while improving removal of certain waste products. The trial is complete, but results are not yet published.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ELISIO-HX dialyzer (a device used in hemodialysis to filter blood)
What this could lead to
If successful, this could provide a safer and more effective option for filtering waste from the blood in people with kidney failure.
What could go wrong
This is a small, early-stage safety study with only 22 participants, so results may not apply to all patients. The device is not a cure and only manages kidney failure temporarily.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RENAL FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Davita Clinical Research

    Norfolk, Virginia, 23517, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.